Insmed (INSM)
NASDAQ: INSM
· Real-Time Price · USD
157.16
4.36 (2.85%)
At close: Oct 03, 2025, 3:59 PM
158.00
0.53%
After-hours: Oct 03, 2025, 07:46 PM EDT
2.85% (1D)
| Bid | 155.29 |
| Market Cap | 33.22B |
| Revenue (ttm) | 398.11M |
| Net Income (ttm) | -1.03B |
| EPS (ttm) | -5.8 |
| PE Ratio (ttm) | -27.1 |
| Forward PE | -40.32 |
| Analyst | Strong Buy |
| Dividends | n/a |
| Ask | 160 |
| Volume | 3,438,452 |
| Avg. Volume (20D) | 2,569,501 |
| Open | 152.63 |
| Previous Close | 152.80 |
| Day's Range | 151.87 - 158.19 |
| 52-Week Range | 60.40 - 158.19 |
| Beta | 1.03 |
| Ex-Dividend Date | n/a |
About INSM
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol INSM
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for INSM stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock ForecastsInsmed is scheduled to release its earnings on
Oct 30, 2025,
before market opens.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
1 month ago
+3.97%
Insmed shares are trading higher after Stifel and ...
Unlock content with
Pro Subscription
1 month ago
+8.07%
Insmed shares are trading higher after the company announced it received FDA approval for BRINSUPRI.
